BREAKDOWN: Health Care Private Equity Federal Reports

This episode is brought to you by Semafor Healthcare.Delivered weekly from David Lim, Semafor Healthcare connects the dots between decisions in government, business, and technology to reveal how they impact the future of healthcare. Each edition will provide the analysis you need to understand and stay ahead of a rapidly changing landscape. Subscribe for free.Health Affairs' Jeff Byers welcomes Senior Editor Kathleen Haddad back to the program to discuss two recent reports exploring the impacts of private equity on the US health care system. Health Affairs published an ahead-of-print article from Michelle S. Rockwell and coauthors exploring demographic variation in COVID-19-associated outpatient hydroxychloroquine and ivermectin use and spending throughout the public health emergency. Also, join a live recording of A Health Podyssey on March 12 featuring Rob Lott and Yashaswini Singh discussing her recent paper on the effect of private equity on physician turnover.  Register for the live taping here.Related Articles:HHS Releases Report on Consolidation and Private Equity (PE) in Health Care MarketsFTC retains stricter merger guidelines under Trump (Healthcare Dive)REPORT: Profits Over Patients: The Harmful Effects of Private Equity on the U.S. Health Care SystemREPORT: HHS Consolidation in Health Care Markets RFI Response  Subscribe to Semafor Healthcare for free.